Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-151,950
Closed -$8.78M 148
2023
Q3
$8.78M Sell
151,950
-10,490
-6% -$661K 0.76% 38
2023
Q2
$10.1M Sell
162,440
-735
-0.5% -$49.1K 0.76% 39
2023
Q1
$11.8M Buy
163,175
+7,110
+5% +$556K 1.02% 26
2022
Q4
$12.5M Buy
156,065
+410
+0.3% +$31.4K 1.19% 21
2022
Q3
$10.4M Sell
155,655
-21,300
-12% -$1.57M 1.13% 19
2022
Q2
$13.4M Buy
176,955
+1,250
+0.7% +$94.9K 1.23% 15
2022
Q1
$14M Buy
+175,705
New +$12.8M 0.96% 27

Other funds holding INCY

CSM Advisors's INCY Position: Q4 2023 in Review

CSM Advisors sold out of Incyte (INCY) in Q4 2023, closing a stake of 151,950 shares — an estimated $8.78M sold.

CSM Advisors first reported a position in INCY in Q1 2022 and held it in 7 quarters. The position peaked at $14M in Q1 2022. 557 funds tracked by Wall St. Rank hold INCY as of Q4 2023.

  • CSM Advisors reported no remaining Incyte position as of Q4 2023 after selling out during the quarter.
  • CSM Advisors sold 151,950 Incyte shares in Q4 2023, an estimated $8.78M.
  • CSM Advisors first reported a position in Incyte in Q1 2022 and held it in 7 quarters.
  • CSM Advisors's Incyte position peaked at $14M in Q1 2022.
  • 557 funds tracked by Wall St. Rank held Incyte as of Q4 2023.

Based on CSM Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.